Enhancement by α-fluoromethylhistidine of the thiopental sleep-prolonging action of Δ9-tetrahydrocannabinol

Ryozo Oishi, Yoshinori Itoh, Masahiro Nishibori, Kiyomi Saeki, Showa Ueki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effect of α-fluoromethylhistidine (α-FMH), a specific inhibitor of histidine decarboxylase, on the potentiation of thiopental-induced sleep by Δ9-tetrahydrocannabinol (THC), which inhibits the histamine turnover in the brain, was examined in mice and rats. The sleeping time after injection of thiopental sodium (40 mg/kg, IV) was prolonged by THC (10 mg/kg, IP, 1 h before) to approximately twice the control value. α-FMH (50 mg/kg, IP) administered alone had no significant influence on the thiopental sleeping time. However, α-FMH given 1 or 3 h before THC treatment markedly enhanced the THC potentiation of thiopental-induced sleep. Such an enhancement by α-FMH was not observed when α-FMH was administered 15 h before THC treatment. The brain histamine level decreased by 60% during the first 4 h after α-FMH injection and remained low until 15 h after the treatment. The thiopental sleep-potentiating action of morphine, chlorpromazine and diazepam was not affected by pretreatment with α-FMH. The transient enhancing effect of α-FMH on the THC potentiation of thiopental-induced sleep suggests that the histaminergic system is one of the activating transmitter systems in the brain.

Original languageEnglish
Pages (from-to)77-81
Number of pages5
JournalPsychopharmacology
Volume95
Issue number1
DOIs
Publication statusPublished - May 1988

Fingerprint

Dronabinol
Thiopental
Sleep
Histamine
Brain
Histidine Decarboxylase
Injections
Chlorpromazine
Diazepam
Morphine
Therapeutics

Keywords

  • Δ-Tetrahydrocannabinol
  • α-Fluoromethylhistidine
  • Histamine
  • Thiopental sleep

ASJC Scopus subject areas

  • Pharmacology

Cite this

Enhancement by α-fluoromethylhistidine of the thiopental sleep-prolonging action of Δ9-tetrahydrocannabinol. / Oishi, Ryozo; Itoh, Yoshinori; Nishibori, Masahiro; Saeki, Kiyomi; Ueki, Showa.

In: Psychopharmacology, Vol. 95, No. 1, 05.1988, p. 77-81.

Research output: Contribution to journalArticle

Oishi, Ryozo ; Itoh, Yoshinori ; Nishibori, Masahiro ; Saeki, Kiyomi ; Ueki, Showa. / Enhancement by α-fluoromethylhistidine of the thiopental sleep-prolonging action of Δ9-tetrahydrocannabinol. In: Psychopharmacology. 1988 ; Vol. 95, No. 1. pp. 77-81.
@article{c8039ec89cda425faa5dd8d6249e6939,
title = "Enhancement by α-fluoromethylhistidine of the thiopental sleep-prolonging action of Δ9-tetrahydrocannabinol",
abstract = "The effect of α-fluoromethylhistidine (α-FMH), a specific inhibitor of histidine decarboxylase, on the potentiation of thiopental-induced sleep by Δ9-tetrahydrocannabinol (THC), which inhibits the histamine turnover in the brain, was examined in mice and rats. The sleeping time after injection of thiopental sodium (40 mg/kg, IV) was prolonged by THC (10 mg/kg, IP, 1 h before) to approximately twice the control value. α-FMH (50 mg/kg, IP) administered alone had no significant influence on the thiopental sleeping time. However, α-FMH given 1 or 3 h before THC treatment markedly enhanced the THC potentiation of thiopental-induced sleep. Such an enhancement by α-FMH was not observed when α-FMH was administered 15 h before THC treatment. The brain histamine level decreased by 60{\%} during the first 4 h after α-FMH injection and remained low until 15 h after the treatment. The thiopental sleep-potentiating action of morphine, chlorpromazine and diazepam was not affected by pretreatment with α-FMH. The transient enhancing effect of α-FMH on the THC potentiation of thiopental-induced sleep suggests that the histaminergic system is one of the activating transmitter systems in the brain.",
keywords = "Δ-Tetrahydrocannabinol, α-Fluoromethylhistidine, Histamine, Thiopental sleep",
author = "Ryozo Oishi and Yoshinori Itoh and Masahiro Nishibori and Kiyomi Saeki and Showa Ueki",
year = "1988",
month = "5",
doi = "10.1007/BF00212771",
language = "English",
volume = "95",
pages = "77--81",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Enhancement by α-fluoromethylhistidine of the thiopental sleep-prolonging action of Δ9-tetrahydrocannabinol

AU - Oishi, Ryozo

AU - Itoh, Yoshinori

AU - Nishibori, Masahiro

AU - Saeki, Kiyomi

AU - Ueki, Showa

PY - 1988/5

Y1 - 1988/5

N2 - The effect of α-fluoromethylhistidine (α-FMH), a specific inhibitor of histidine decarboxylase, on the potentiation of thiopental-induced sleep by Δ9-tetrahydrocannabinol (THC), which inhibits the histamine turnover in the brain, was examined in mice and rats. The sleeping time after injection of thiopental sodium (40 mg/kg, IV) was prolonged by THC (10 mg/kg, IP, 1 h before) to approximately twice the control value. α-FMH (50 mg/kg, IP) administered alone had no significant influence on the thiopental sleeping time. However, α-FMH given 1 or 3 h before THC treatment markedly enhanced the THC potentiation of thiopental-induced sleep. Such an enhancement by α-FMH was not observed when α-FMH was administered 15 h before THC treatment. The brain histamine level decreased by 60% during the first 4 h after α-FMH injection and remained low until 15 h after the treatment. The thiopental sleep-potentiating action of morphine, chlorpromazine and diazepam was not affected by pretreatment with α-FMH. The transient enhancing effect of α-FMH on the THC potentiation of thiopental-induced sleep suggests that the histaminergic system is one of the activating transmitter systems in the brain.

AB - The effect of α-fluoromethylhistidine (α-FMH), a specific inhibitor of histidine decarboxylase, on the potentiation of thiopental-induced sleep by Δ9-tetrahydrocannabinol (THC), which inhibits the histamine turnover in the brain, was examined in mice and rats. The sleeping time after injection of thiopental sodium (40 mg/kg, IV) was prolonged by THC (10 mg/kg, IP, 1 h before) to approximately twice the control value. α-FMH (50 mg/kg, IP) administered alone had no significant influence on the thiopental sleeping time. However, α-FMH given 1 or 3 h before THC treatment markedly enhanced the THC potentiation of thiopental-induced sleep. Such an enhancement by α-FMH was not observed when α-FMH was administered 15 h before THC treatment. The brain histamine level decreased by 60% during the first 4 h after α-FMH injection and remained low until 15 h after the treatment. The thiopental sleep-potentiating action of morphine, chlorpromazine and diazepam was not affected by pretreatment with α-FMH. The transient enhancing effect of α-FMH on the THC potentiation of thiopental-induced sleep suggests that the histaminergic system is one of the activating transmitter systems in the brain.

KW - Δ-Tetrahydrocannabinol

KW - α-Fluoromethylhistidine

KW - Histamine

KW - Thiopental sleep

UR - http://www.scopus.com/inward/record.url?scp=0023821365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023821365&partnerID=8YFLogxK

U2 - 10.1007/BF00212771

DO - 10.1007/BF00212771

M3 - Article

C2 - 2838862

AN - SCOPUS:0023821365

VL - 95

SP - 77

EP - 81

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -